54 related articles for article (PubMed ID: 17088923)
1. Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?
Murthy PB; Sexton WJ
J Urol; 2023 Nov; 210(5):726-727. PubMed ID: 37757487
[No Abstract] [Full Text] [Related]
2. Primary Chemoablation for Intermediate-Risk Low-Grade Bladder Cancer: New Paradigm or Added Uncertainty? Letter.
Prasad SM
J Urol; 2023 Dec; 210(6):840. PubMed ID: 37769639
[No Abstract] [Full Text] [Related]
3. Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
Yuk HD; Kim JK; Jeong CW; Kwak C; Kim HH; Ku JH
Biomed Res Int; 2018; 2018():9432606. PubMed ID: 30271788
[TBL] [Abstract][Full Text] [Related]
4. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
5. Incrusted cystitis after intravesical mitomycin C treatment.
Llopis M; Moreno J; Botella R; Algado M
Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
[TBL] [Abstract][Full Text] [Related]
6. Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor.
Onishi T; Sasaki T; Hoshina A; Yabana T
Anticancer Res; 2011 Apr; 31(4):1471-4. PubMed ID: 21508405
[TBL] [Abstract][Full Text] [Related]
7. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
Oosterlinck W
Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
[No Abstract] [Full Text] [Related]
8. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
9. [Calcified bladder lesions secondary to the instillation of mitomycin C].
Megias Garrigós J; Pelluch Auladell A; Romero Pérez P; Fernandez García J; Gassó Matoses M; Sánchez Marcos M; Mira Llinarés A
Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206
[TBL] [Abstract][Full Text] [Related]
10. Papillary-like bladder calcifications following intravescical mitomycin C. A case report.
Fiore AA; Iorio B; Vennarecci G; Venditti D; Cervelli V; Giudiceandrea F; Casciani CU
Minerva Urol Nefrol; 1993 Dec; 45(4):171-3. PubMed ID: 8023227
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]